The Truth About Acne

Tips to control zits.

If your acne is bothering you, it makes sense to talk to your doctor about a solution that may be right for you. In the meantime, you can also follow these simple tips to help keep your skin healthy and pimple-free.

KEEP IT CLEAN

Use a mild, soap-free, fragrance-free cleanser like Cetaphil® DERMACONTROL™ Oil Control Foam Wash and apply gently, morning and night. There's no need to wash more than twice a day and you don't have to scrub hard. Also, avoid alcohol-based cleansers, which can actually cause irritation and aggravate acne.

BE SMART ABOUT THE SUN

Too much sun is bad for your skin, and it's even worse when you suffer from breakouts. Try to stay out of direct sunlight as much as you can. When you do go out, use a non-clogging sunscreen (it might say "non-comedogenic" on the package) that's specifically formulated for your face, like Cetaphil® DERMACONTROL™ Oil Control Moisturizer SPF 30.

DON'T SQUEEZE

When you squeeze or pick at pimples, you can actually push the infection deeper into your skin and make matters worse. It can even cause scarring, so try to leave them alone.

THINK LONG TERM

Don't stop after you see short-term results. Acne is a commonly recurring condition, so it's important to continue your treatment. Epiduo® Gel works below the surface to prevent new breakouts from forming where you can't see them.

Email

CHECK OUT OUR COMMERCIAL >

Important Safety Information
Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/ burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‐800‐FDA‐1088.

1.*This offer is not valid if prescriptions are paid by any state or other federally funded programs, including, but not limited to Medicare or Medicaid, Medigap, VA, DoD, or TRICARE®. 2. This card is good for use only with an Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% prescription at the time the prescription is filled by the pharmacist and dispensed to the patient. 3. Offer good only in the USA at participating retail pharmacies and cannot be redeemed at government-subsidized clinics. 4. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law. 5. By using this card, you demonstrate that you understand and agree to comply with the terms and conditions of this offer as set forth on this card. 6. Actual payment for product will depend on individual insurance coverage.

GALDERMA LABORATORIES, L.P. RESERVES THE RIGHT TO RESCIND, REVOKE, OR AMEND THIS OFFER WITHOUT NOTICE AT ANY TIME.

©2014 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Important Safety Information

Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/ burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Share the news

Send me a copy of this email

See Privacy Policy >